FDA needs cure for conflict

After years of unrestrained pharmaceutical influence, the federal Food and Drug Administration has completely lost its way. Scientists, educators, industry and political insiders have documented, over and over again, how the agency has lost its independence and mission in the past decade. Critics charge that the FDA treats the pharmaceutical industry as its client, rather the public and public health.

President Obama didn’t help the problem when he appointed Robert M. Califf to head the agency. Called a “big pharma mega-lobbyist” and the “ultimate industry insider,” he received millions in funding and salary support from Eli Lilly, Merck, Novartis and other drug companies. Worse, Califf was a board member and consultant for a company whose sole purpose is to help pharmaceutical companies evade and manipulate FDA regulations.

So a perfect choice for the job. Between 2009 and 2011, prescription drug, biotechnology and medical device companies spent more than $700 million lobbying Congress and the Obama administration. That’s certainly enough to guarantee one of their own received the job.

With such a conflict of interest, U.S. citizens, or consumers, as we are more often labeled, cannot rely on the FDA’s decisions, which is frightening, given that the FDA supposed to protect us, the would-be medicine takers.

So leave it to our nation’s unofficial, trustworthy consumer watchdog, the magazine Consumer Reports, (which hires its own independent drug safety experts to conduct the tests) to warn us clearly and unequivocally to stay away from the highly advertised, new drug called Belsomra to treat insomnia. The top three reasons: It’s expensive ($70 for seven pills), barely works and poses serious safety concerns. Next-day problems after taking the drug included driving accidents, traffic tickets, hallucinations or sleep paralysis — a feeling that you can’t move or talk while falling asleep or awakening.

“The FDA has set a disturbing precedent by approving an untested dose of a drug. For a deadly cancer with limited treatment this gamble might make sense, but not for a condition like insomnia and where Belsomra doesn’t appear to work any better, or more safely, than available treatments,” said Dr. Lisa M. Schwartz at the Geisel School of Medicine at Dartmouth, one of the experts hired by Consumer Reports.

The magazine’s medical advisers say that a sleeping pill is usually not the best treatment for insomnia. Instead, cognitive behavioral therapy, which involves talking to a therapist to learn a new set of behaviors regarding sleep, is as effective as sleeping pills, and has been shown to help up to 80 percent of chronic insomnia sufferers. Studies have found that relaxation training, setting and sticking to consistent bedtimes and wake-up times, regular exercise, quitting smoking, cutting back on caffeine and alcohol in the afternoon and evening, keeping your bedroom quiet and dark, and not watching TV or using smartphones in bed can help relieve insomnia.

Americans deserve a real public health agency again; lobbyists are definitely contraindicated.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Wednesday, Nov. 27

A sketchy look at the news of the day.… Continue reading

FILE — Bill Nye, the science educator, in New York, March 5, 2015. Nye filed a $37 million lawsuit against Disney and its subsidiaries on Aug. 25, 2017, alleging that he was deprived of extensive profits from his show “Bill Nye, the Science Guy,” which ran on PBS from 1993 to 1998. (Jake Naughton/The New York Times)
Editorial: What saved climate act? Good sense and a Science Guy

A majority kept the Climate Commitment Act because of its investments, with some help from Bill Nye.

Comment: Make Thanksgiving table big enough for all voters

You don’t have to see eye-to-eye to see the humanity in others, especially family and friends.

Comment: As seniors age, adapt celebrations to their comfort

Traditions like Mom’s stuffing can be honored, but maybe with some help or other accommodations.

Douthat: Three theories on what Trump’s Cabinet picks portend

Will his Cabinet act more as a coalition government, a team of rivals or a team of podcasters?

Comment: Has Nancy Mace ever been in a women’s restroom

Her call to bar a trans member of Congress from women’s facilities makes sense only as a performance.

FILE - In this Jan. 22, 2019, file photo, Washington Supreme Court Justice Steven González listens to testimony during a hearing in Olympia, Wash. González has been elected as the next chief justice of the Washington state Supreme Court. He was elected by his colleagues on Thursday, Nov. 5, 2020, according to a news release sent by the court. (AP Photo/Ted S. Warren, File)
Editorial: Daunting fix to fund right to public defenders

With a court system in crisis, threatening justice, local governments say they can’t pick up the tab.

Killer whales not trapped in nets during the 1970 Penn Cove capture stayed near penned kin until the last one was hauled away on a truck. (Wallie Funk/Whidbey News-Times file)
Editorial: After 50 years, the message in orcas’ Penn Cove return

The return by L pod, following deadly roundups in 1970-71, should serve as a reminder of responsibility.

FILE — Rep. Marie Gluesenkamp Perez (D-Wash.) on a ride-along with a Skamania County paramedic captain near Carson, Wash. on Feb. 26, 2024. Perez, who is on track to win re-election in her rural Washington district, says her party needs to stop demonizing others and recruit candidates from diverse backgrounds. (M. Scott Brauer/The New York Times)
Editorial: What Washington state’s results say about election

Both parties should consider what state voters had to say on the economy and government investments.

toon
Editorial cartoons for Tuesday, Nov. 26

A sketchy look at the news of the day.… Continue reading

Comment: Navigating Medicare options an unnecessary headache

Simplifying Medicare could increase competition, save taxpayers money and protect its solvency.

Ask city of Snohomish residents what they want at park

Snohomish residents living west of Avenue D will soon be getting their… Continue reading

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.